SCHEMBL21030989

SCHEMBL21030989

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3-c3c4ccccc4nc4oc5ccccc5c34)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ ATM Q13315 2/20 0.37
▸ PDE5A O76074 3/20 0.36
▸ TSHR P16473 5/20 0.36
▸ ALDH1A1 P00352 5/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ LMNA P02545 3/20 0.36
▸ ALOX15 P16050 2/20 0.36
▸ USP2 O75604 2/20 0.36
▸ TP53 P04637 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ ABCG2 Q9UNQ0 4/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA2B P29275 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ MAPT P10636 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25847819 0.97 MEN1 (0.38) MEN1KMT2AATMPDE5ATSHR
SCHEMBL25847820 0.93 ABCG2 (0.34) MEN1KMT2AATMPDE5ATSHR
SCHEMBL21031470 0.90 HPGD (0.42) TSHRALDH1A1HSD17B10LMNAUSP2
SCHEMBL21032077 0.89 MEN1 (0.40) MEN1KMT2AATMPDE5ATSHR
SCHEMBL21032092 0.88 MEN1 (0.42) MEN1KMT2AATMPDE5ATSHR
SCHEMBL21030995 0.88 HPGD (0.40) MEN1KMT2ATSHRALDH1A1HSD17B10
SCHEMBL21030665 0.86 MEN1 (0.41) MEN1KMT2AATMPDE5ATSHR
SCHEMBL21031308 0.86 MEN1 (0.41) MEN1KMT2AATMPDE5ATSHR
SCHEMBL21031301 0.86 MEN1 (0.41) MEN1KMT2AATMPDE5ATSHR
SCHEMBL21031256 0.86 MEN1 (0.41) MEN1KMT2AATMPDE5ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885ATM 3827/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885ATM 3827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback